Dear Editor, We are glad to have the opportunity to explain our letter [1] dealing with acute respiratory distress syndrome (ARDS). Dr. Marcus Schultz wonders whether the ''infectious ARDS cases'' are truly pneumonias and whether they may be cases of ''noninfectious ARDS'', as a consequence of intraoperative ventilation [2] . Dr. M. Schultz thought our patients developed ARDS within 1 week after surgery. However, our patients occurred ARDS within 6 months after transplantation, which was clearly described in our letter. In fact, approximately 80 % (60/72) of patients involved in the present study occurred within 4 months following renal transplantation and 76.4 % (55/ 72) between 3 and 4 months. Patients experienced an average duration of 97.5 days between renal transplantation and ARDS onset [interquartile range (IQR) 80.0-110.8 days]. Only one patient developed ARDS within 1 week after transplantation, and he did so 6 days after the operation.
In our other study regarding ARDS due to pneumonia including within and beyond 6 months posttransplantation, we found that approximately 80 % (76/94) of ARDS occurred within 6 months following renal transplantation. Patients experienced an average duration of 102.5 days between renal transplantation and ARDS onset (IQR 82.8-153.3 days), which was in agreement with a previous study [3] suggesting that onset of infection was 85.8 ± 20.2 days postoperation in cytomegalovirus (CMV) infection accompanied by ARDS after renal transplantation.
ARDS was defined as arterial oxygen partial pressure/oxygen inspiratory fraction (PaO 2 /FiO 2 ) ratio B300, with positive end expiratory pressure C5 cm H 2 O, accompanied within 1 week by: (1) a known clinical insult or new or worsening respiratory symptoms; (2) bilateral opacities on chest radiographs; and (3) respiratory failure not fully explained by cardiac failure or fluid overload. ARDS severity was categorized as mild (200 mmHg \ PaO 2 / FiO 2 B 300 mmHg), moderate (100 mmHg \ PaO 2 / FiO 2 B 200 mmHg), or severe (PaO 2 /FiO 2 B 100 mmHg). Both ARDS and its severity were measured according to the Berlin definition [4] . The diagnosis of pneumonia was defined in accordance with the criteria set by the Infectious Diseases Society of America/American Thoracic Society [5, 6] . All patients enrolled underwent X-ray chest and serological blood tests for CMV-PP65 antigen, anti-CMV IgG antibody, and anti-CMV IgM antibody, and/or CMV-DNA sputum analysis. Some patients received high-resolution computed tomography (CT) examinations and/or bronchoalveolar lavage (BAL). The ''infectious ARDS cases'' were indeed pneumonias.
